Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Dept. of Surgery, Nakashibetsu Municipal Hospital.
A 75-year-old woman was admitted to our hospital with advanced breast cancer (T4bN3M0, Stage IIIb). She received chemoendocrine therapy of 5'-DFUR 800 mg/day and MPA 800 mg/ day for 2 months. The main tumor and metastatic lymph nodes were remarkably reduced and became resectable. Histological examination revealed necrotic change of the tumor tissues. This combination therapy proved very useful for advanced breast cancer.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on